A non-randomized comparison of gemcitabine-based chemoradiation with or without induction chemotherapy for locally advanced squamous cell carcinoma of the head and neck

BMC Cancer

Volumn 9, Issue , 2009, Pages

  Specenier, Pol M ^a   Weyler, Joost ^b   Van Laer, Carl ^a   Van den Weyngaert, Danielle ^b   Van den Brande, Jan ^a   Huizing, Manon T ^a   Altintas, Sevilay ^a   Vermorken, Jan B ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; DOCETAXEL; FLUOROURACIL; GEMCITABINE; IFOSFAMIDE; PACLITAXEL; ANTINEOPLASTIC ANTIMETABOLITE; DEOXYCYTIDINE; DRUG DERIVATIVE; RADIOSENSITIZING AGENT;

ADULT; ADVANCED CANCER; AGE DISTRIBUTION; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATITIS; DIARRHEA; DISTANT METASTASIS; DRUG FATALITY; FATIGUE; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; HYPOPHARYNX CARCINOMA; LARYNX CARCINOMA; LOW DRUG DOSE; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NASOPHARYNX CARCINOMA; NEUTROPENIA; OROPHARYNX CARCINOMA; OVERALL SURVIVAL; PARANASAL SINUS CARCINOMA; PROGRESSION FREE SURVIVAL; RADIATION DOSE; SEPTIC SHOCK; SIDE EFFECT; SQUAMOUS CELL CARCINOMA; THROMBOCYTOPENIA; TREATMENT OUTCOME; WEIGHT REDUCTION; AGED; COHORT ANALYSIS; HEAD AND NECK TUMOR; METASTASIS; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PROPORTIONAL HAZARDS MODEL;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COHORT STUDIES; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PROPORTIONAL HAZARDS MODELS; RADIATION-SENSITIZING AGENTS; TREATMENT OUTCOME;

EID: 69349084107     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-273     Document Type: Article

References (20)

1. Vermorken JB Medical treatment in head and neck cancer Ann Oncol 2005, 16:iI258-ii264. 10.1093/annonc/mdi735 15958469
2. Pignon JP Bourhis J Domenge C Designe L Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer Lancet 2000, 355:949-955. 10768432
3. Bourhis J Armand JP Pignon P on behalf of the MACH-NC Collaborative Group Update of MACH-NC (Meta-Analysis of Chemotherapy in Head and Neck cancer) database focused on concomitant chemoradiotherapy J Clin Oncol 2004, 22(14S):5505.
4. Posner MR Hershock DM Blajman CR et al Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer N Engl J Med 2007, 357:1705-1715. 10.1056/NEJMoa070956 17960013
5. Vermorken JB Remenar E van Herpen C et al Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer N Engl J Med 2007, 357:1695-1704. 10.1056/NEJMoa071028 17960012
6. Hitt R Lopez-Pousa A Martinez-Trufero J et al Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer J Clin Oncol 2005, 23:8636-8645. 10.1200/ JCO.2004.00.1990 16275937
7. Specenier PM Vermorken JB Neoadjuvant chemotherapy in head and neck cancer: Should it be revisited? Cancer Lett 2007, 256:166-177. 10.1016/ j.canlet.2007.06.015 17673364
8. Posner M Vermorken JB Induction therapy in the modern era of combined-modality therapy for locally advanced head and neck cancer Semin Oncol 2008, 35:221-228. 10.1053/j.seminoncol.2008.03.007 18544437
9. Specenier PM Weyngaert Van den D Van Laer C et al Phase II feasibility study of concurrent radiotherapy and gemcitabine in chemonaive patients with squamous cell carcinoma of the head and neck: Long-term follow up data Ann Oncol 2007, 18:856-860.
10. Adelstein DJ Li Y Adams GL et al An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer J Clin Oncol 2003, 21:92-98. 10.1200/JCO.2003.01.008 12506176
11. Langendijk JA de Jong MA Leemans CR et al Postoperative radiotherapy in squamous cell carcinoma of the oral cavity: The importance of the overall treatment time Int J Radiat Oncol Biol Phys 2003, 57:693-700. 14529773
12. Suwinski R Sowa A Rutkowski T et al Time factor in postoperative radiotherapy: A multivariate locoregional control analysis in 868 patients Int J Radiat Oncol Biol Phys 2003, 56:399-412. 10.1016/ S0360-3016(02)04469-3 12738315
13. Tarnawki R Fowler J Skladowski K et al How fast is repopulation of tumor cells during the treatment gap? Int J Radiat Oncol Biol Phys 2002, 54:229 -236. 12182996
14. Hoffstetter S Marchal C Peiffert D et al Treatment duration as a prognostic factor for local control and survival in epidermoid carcinoma of the tonsillar region treated by combined external beam irradiation and brachytherapy Radiother Oncol 1997, 45:141-148. 10.1016/ S0167-8140(97)00119-9 9424004
15. Domenge C Hill C Lefebvre JL et al Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma. French Groupe d'Etude des Tumeurs de la Tete et du Cou (GETTEC) Br J Cancer 2000, 83:1594-1598. 10.1054/bjoc.2000.1512 11189100
16. Paccagnella A Orlando A Marchiori C et al Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: A study by the Gruppo di Studio sui Tumori della Testa e del Collo J Natl Cancer Inst 1994, 86:265-272. 10.1093/jnci/86.4.265 8158680
17. Zorat PL Paccagnella A Cavaniglia G et al Randomized phase III trial of neoadjuvant chemotherapy in head and neck cancer: 10-year follow-up J Natl Cancer Inst 2004, 96:1714-1717. 15547184
18. Graf R Hildebrandt B Tilly W et al A non-randomised, single-centre comparison of induction chemotherapy followed by radiochemotherapy versus concomitant chemotherapy with hyperfractionated radiotherapy in inoperable head and neck carcinomas BMC Cancer 2006, 6:30s. 10.1186/ 1471-2407-6-30 1403790 16451730
19. Hitt R Grau JJ Lopez-Pousa A et al Final results of a randomized phase III trial comparing induction chemotherapy with cisplatin/5-FU or docetaxel/cisplatin/5-FU follow by chemoradiotherapy (CRT) versus CRT alone as first-line treatment of unresectable locally advanced head and neck cancer (LAHNC) J Clin Oncol 2009, 27(15s):6009.
20. Paccagnella A Buffoli A Koussis H et al Concomitant chemoradiotherapy (CT/RT) vs neoadjuvant chemotherapy with docetaxel/cispaltin/ 5-fluorouracil (TPF) followed by CT/RT in locally advanced head and neck cancer. Final results of a phase II randomized study J Clin Oncol 2008, 26(20S):6000.